A Multi-center, Single Arm , Phase II Study of Atezolizumab Combined With Concurrent Chemoradiotherapy and Maintenance Therapy With Atezolizumab in Untreated Participants With Extensive-stage Small Cell Lung Cancer
Latest Information Update: 16 Jun 2022
At a glance
- Drugs Atezolizumab (Primary) ; Carboplatin (Primary) ; Cisplatin (Primary) ; Etoposide (Primary)
- Indications Brain metastases; Small cell lung cancer
- Focus Adverse reactions
- 23 May 2022 Status changed from recruiting to completed.
- 25 Nov 2020 New trial record